| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3269639 | HPB | 2011 | 8 Pages |
Abstract
Compared with patients undergoing complete operative IPMN clearance, patients with residual IPMN after segmental pancreatectomy do not demonstrate increased risk for the development of invasive disease or reduced survival. In patients without residual IPMN who later develop new IPMN, the risk for invasive IPMN is increased.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Jacob R. Miller, Juliana E. Meyer, Joshua A. Waters, Mohammad Al-Haddad, John DeWitt, Stuart Sherman, Keith D. Lillemoe, C. Max Schmidt,
